INSTIL BIO INC (TIL) Stock Fundamental Analysis

NASDAQ:TIL • US45783C2008

7.99 USD
+0.21 (+2.7%)
At close: Feb 13, 2026
7.76 USD
-0.23 (-2.88%)
After Hours: 2/6/2026, 8:08:30 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall TIL gets a fundamental rating of 2 out of 10. We evaluated TIL against 522 industry peers in the Biotechnology industry. TIL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TIL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year TIL has reported negative net income.
  • TIL had a negative operating cash flow in the past year.
  • TIL had negative earnings in each of the past 5 years.
  • In the past 5 years TIL always reported negative operating cash flow.
TIL Yearly Net Income VS EBIT VS OCF VS FCFTIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M -250M

1.2 Ratios

  • With a decent Return On Assets value of -35.45%, TIL is doing good in the industry, outperforming 61.38% of the companies in the same industry.
  • TIL has a Return On Equity of -62.34%. This is in the better half of the industry: TIL outperforms 60.23% of its industry peers.
Industry RankSector Rank
ROA -35.45%
ROE -62.34%
ROIC N/A
ROA(3y)-40.76%
ROA(5y)-31.96%
ROE(3y)-58.04%
ROE(5y)-43.06%
ROIC(3y)N/A
ROIC(5y)N/A
TIL Yearly ROA, ROE, ROICTIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • TIL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TIL Yearly Profit, Operating, Gross MarginsTIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -5K -10K -15K -20K -25K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, TIL has more shares outstanding
  • The number of shares outstanding for TIL has been reduced compared to 5 years ago.
  • The debt/assets ratio for TIL is higher compared to a year ago.
TIL Yearly Shares OutstandingTIL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TIL Yearly Total Debt VS Total AssetsTIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • TIL has an Altman-Z score of -4.15. This is a bad value and indicates that TIL is not financially healthy and even has some risk of bankruptcy.
  • TIL has a Altman-Z score (-4.15) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.70 indicates that TIL is somewhat dependend on debt financing.
  • The Debt to Equity ratio of TIL (0.70) is worse than 71.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z -4.15
ROIC/WACCN/A
WACCN/A
TIL Yearly LT Debt VS Equity VS FCFTIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • TIL has a Current Ratio of 34.45. This indicates that TIL is financially healthy and has no problem in meeting its short term obligations.
  • TIL's Current ratio of 34.45 is amongst the best of the industry. TIL outperforms 98.47% of its industry peers.
  • A Quick Ratio of 34.45 indicates that TIL has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 34.45, TIL belongs to the top of the industry, outperforming 98.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 34.45
Quick Ratio 34.45
TIL Yearly Current Assets VS Current LiabilitesTIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.47% over the past year.
EPS 1Y (TTM)1.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, TIL will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.17% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2.09%
EPS Next 2Y22.88%
EPS Next 3Y8.17%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TIL Yearly Revenue VS EstimatesTIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
TIL Yearly EPS VS EstimatesTIL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TIL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TIL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TIL Price Earnings VS Forward Price EarningsTIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TIL Per share dataTIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.88%
EPS Next 3Y8.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for TIL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INSTIL BIO INC

NASDAQ:TIL (2/13/2026, 8:00:00 PM)

After market: 7.76 -0.23 (-2.88%)

7.99

+0.21 (+2.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13
Earnings (Next)03-02
Inst Owners67.56%
Inst Owner Change-98.82%
Ins Owners4.53%
Ins Owner Change0%
Market Cap54.17M
Revenue(TTM)N/A
Net Income(TTM)-75.08M
Analysts77.5
Price Target53.55 (570.21%)
Short Float %7.71%
Short Ratio3.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.35%
Min EPS beat(2)-28.19%
Max EPS beat(2)15.49%
EPS beat(4)2
Avg EPS beat(4)-8.5%
Min EPS beat(4)-65.34%
Max EPS beat(4)44.04%
EPS beat(8)4
Avg EPS beat(8)-13.96%
EPS beat(12)6
Avg EPS beat(12)-54.16%
EPS beat(16)7
Avg EPS beat(16)-42.76%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-45.17%
PT rev (3m)-45.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)19.8%
EPS NY rev (1m)4.49%
EPS NY rev (3m)5.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.45
P/tB 0.45
EV/EBITDA N/A
EPS(TTM)-11.39
EYN/A
EPS(NY)-5.58
Fwd EYN/A
FCF(TTM)-7.39
FCFYN/A
OCF(TTM)-5.91
OCFYN/A
SpS0
BVpS17.76
TBVpS17.76
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -35.45%
ROE -62.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-40.76%
ROA(5y)-31.96%
ROE(3y)-58.04%
ROE(5y)-43.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 791.77%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 34.45
Quick Ratio 34.45
Altman-Z -4.15
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)707.89%
Cap/Depr(5y)4754.54%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.22%
EPS Next Y-2.09%
EPS Next 2Y22.88%
EPS Next 3Y8.17%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y64.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.03%
OCF growth 3YN/A
OCF growth 5YN/A

INSTIL BIO INC / TIL FAQ

What is the fundamental rating for TIL stock?

ChartMill assigns a fundamental rating of 2 / 10 to TIL.


What is the valuation status for TIL stock?

ChartMill assigns a valuation rating of 0 / 10 to INSTIL BIO INC (TIL). This can be considered as Overvalued.


Can you provide the profitability details for INSTIL BIO INC?

INSTIL BIO INC (TIL) has a profitability rating of 1 / 10.


Can you provide the financial health for TIL stock?

The financial health rating of INSTIL BIO INC (TIL) is 4 / 10.